11325826 |
Active Ras induces heterodimerization of cRaf and BRaf
Kalmes, HA,
Rapp, UR,
Weber, CK,
Slupsky, JR
|
Cancer Res. |
2001 |
22510884 |
Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling
Fiala, GJ,
Herr, R,
Röring, M,
Heilmann, K,
Schamel, WW,
Saunders, DN,
Halbach, S,
Capper, D,
Brummer, T,
Braun, S,
von Deimling, A,
Eisenhardt, AE
|
EMBO J. |
2012 |
22043453 |
C-Raf is required for the initiation of lung cancer by K-Ras(G12D)
Frese, KK,
DeNicola, GM,
Baccarini, M,
Karreth, FA,
Tuveson, DA
|
Cancer Discov |
2011 |
17018604 |
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling
Ogilvie, L,
Dumaz, N,
Martin, J,
Bastian, BC,
Hedley, D,
Hayward, R,
Springer, C,
Marais, R,
Curtin, JA
|
Cancer Res. |
2006 |
16508002 |
Regulation and role of Raf-1/B-Raf heterodimerization
O'Neill, E,
Rushworth, LK,
Hindley, AD,
Kolch, W
|
Mol. Cell. Biol. |
2006 |
20141835 |
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF
Reis-Filho, JS,
Heidorn, SJ,
Springer, CJ,
Pritchard, C,
Nourry, A,
Milagre, C,
Whittaker, S,
Dhomen, N,
Marais, R,
Niculescu-Duvas, I,
Hussain, J
|
Cell |
2010 |
16364920 |
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization
Garnett, MJ,
Barford, D,
Paterson, H,
Rana, S,
Marais, R
|
Mol. Cell |
2005 |
24202393 |
Tumor adaptation and resistance to RAF inhibitors
Lito, P,
Solit, DB,
Rosen, N
|
Nat. Med. |
2013 |
25435214 |
Targeting RAS-ERK signalling in cancer: promises and challenges
Poulikakos, PI,
Samatar, AA
|
Nat Rev Drug Discov |
2014 |
20179705 |
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Shokat, KM,
Zhang, C,
Bollag, G,
Rosen, N,
Poulikakos, PI
|
Nature |
2010 |